INDV — Indivior Pharmaceuticals Inc. price, chart and key statistics

Price data

Price

$34.77

YTD price return

-3.09%

YTD total return

-3.09%

Next earnings

Oct 29, 2026

Market cap

4.1B2021-12 524.2M2026-10 4.1B+682.8% over the window

Enterprise value

4.4B

Shares outstanding

118M2021-12 151.9M2026-06 118M-22.3% over the window

52W low

$23.72

52W high

$42.81

From 52W high

-18.78%

From 52W low

+46.59%

52W range

58%

Volume

Rel volume

0.81×

30D volume

2.4M

30D $ vol

83.9M

Fundamentals

Sales (ttm)

1.3B2021-12 791M2026-06 1.3B+68.4% over the window

Sales/share

$11.292021-12 $5.212026-06 $11.29+116.8% over the window

EPS (ttm)

$2.772021-12 $1.352026-06 $2.77+105.2% over the window

FCF (ttm)

-111M2021-12 349M2026-06 -111M-131.8% over the window

FCF/share

-$0.942021-12 $2.302026-06 -$0.94-140.9% over the window

Book value/share

-$1.762021-12 $0.802026-06 -$1.76-321.3% over the window

Net margin

26.65%2021-12 25.9%2026-06 26.7%+2.8% over the window

ROA

28.79%2021-12 11.2%2026-06 28.8%+157.3% over the window

Current ratio

0.842021-12 1.802026-06 0.84-53.5% over the window

Growth (CAGR, ttm) · 10Y

Sales

+13.47%2025-06-30 → 2026-06-301.2B → 1.3B (+13.5% total)+11.83%2022-12-31 → 2026-06-30901M → 1.3B (+47.8% total)+12.29%2021-12-31 → 2026-06-30791M → 1.3B (+68.4% total)n/a

Net income

+228.97%2025-06-30 → 2026-06-30108M → 355M (+228.7% total)n/a+12.99%2021-12-31 → 2026-06-30205M → 355M (+73.2% total)n/a

Shares

-5.42%2025-06-30 → 2026-06-30124.8M → 118M (-5.4% total)-4.57%2022-12-31 → 2026-06-30139M → 118M (-15.1% total)-5.47%2021-12-31 → 2026-06-30151.9M → 118M (-22.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS

+229.61%2025-06-30 → 2026-06-30$0.84 → $2.77 (+229.3% total)n/a+17.33%2021-12-31 → 2026-06-30$1.35 → $2.77 (+105.2% total)n/a

Sales/share

+19.97%2025-06-30 → 2026-06-30$9.41 → $11.29 (+20.0% total)+17.19%2022-12-31 → 2026-06-30$6.48 → $11.29 (+74.1% total)+18.78%2021-12-31 → 2026-06-30$5.21 → $11.29 (+116.8% total)n/a

Price

+43.18%2025-10-20 → 2026-10-20$24.29 → $34.77 (+43.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+23.18%2023-10-20 → 2026-10-20$18.60 → $34.77 (+86.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+61.46%2021-10-20 → 2026-10-20$3.17 → $34.77 (+996.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+24.84%2016-10-19 → 2026-10-20$3.78 → $34.77 (+819.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+43.18%2025-10-20 → 2026-10-20$24.29 → $34.77 (+43.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+23.18%2023-10-20 → 2026-10-20$18.60 → $34.77 (+86.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+61.46%2021-10-20 → 2026-10-20$3.17 → $34.77 (+996.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+24.84%2016-10-19 → 2026-10-20$3.78 → $34.77 (+819.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

12.6×2021-12 2.562026-10 11.56+352.0% over the window

Fwd P/E

6.9×

P/S (ttm)Market cap ÷ TTM revenue.

3.1×2021-12 0.662026-10 3.08+364.9% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-19.7×2021-12 4.332026-10 -19.73-555.4% over the window

EV/EBITDA (fy)

10.2×

EV/Sales (ttm)

3.3×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-2.71%2021-12 66.6%2026-06 -2.3%-103.4% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 118.0M ÷ 124.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

5.42%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (5.42%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

5.42%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($301M) ÷ today's market cap ($4.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

7.34%2021-12 -0.2%2026-06 6.2%-3358.5% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $301M + TTM dividends $0) ÷ today's market cap ($4.1B). Same caveat as the cash buyback yield.

7.34%2021-12 -0.2%2026-06 6.2%-3358.5% over the window

Vs own 10Y history

P/S

68th